Premier Edition of Clinical Lipid Management by Jennifer G. Robinson, MD, MPH, Released
08-03-2016
Clinical Lipid Management presents the newest thinking and data needed for clinicians to reduce atherosclerotic cardiovascular disease (ASCVD) risk. This book provides detailed evidence-based guidance for treating cholesterol to reduce ASCVD with a focus on recent ACC/AHA guidelines, an overview of evidence-based treatment of other risk factors, the management of genetic and acquired lipid disorders, and complete efficacy and safety information on all available lipid-lowering agents, including clinical trial data and FDA-approved labeling.
Clinical Lipid Management provides state of the art guidance on contemporary concepts in lipids management from one of the world’s best positioned key opinion leaders.
Jennifer G. Robinson, MD, MPH is Professor of the Departments of Epidemiology and Medicine (Division of Cardiology), and Director of the Prevention Intervention Center at the University of Iowa College of Medicine.
Dr. Robinson was Vice-Chairman for the 2013 AHA/ACR Cholesterol Guidelines and a member of the 2013 AHA/ACR Cardiology Risk Reduction Guidelines. Dr. Robinson has performed numerous clinical trial sponsored by the NIH and the pharmaceutical industry, including a wide range of anti-atherosclerotic and metabolic agents. Dr. Robinson has published more than 145 peer-reviewed articles in the area of lipid modifying drugs, cardiovascular risk stratification, and cardiovascular disease prevention.
2016 • $49.95 • ISBN: 978-1-943236-02-2 • 608 pages